Efficacy and Safety of Tremella fuciformis in Individuals with Subjective Cognitive Impairment: A Randomized Controlled Trial
Authors:
- 1 April 2018
- journal article
- research article
- Published by SAGE Publications in Journal of Medicinal Food
- Vol. 21 (4) , 400-407
Abstract
The efficacy and safety of Tremella fuciformis (TF) as a nutritional supplement were assessed in individuals with subjective cognitive impairment (SCI). Seventy-five individuals with SCI were enrolled in an 8-week, randomized, double-blind, placebo-controlled trial of TF (600 mg/day, n = 30 or 1200 mg/day, n = 30) or placebo ( n = 15). The primary outcome measure was changes in total scores of the subjective memory complaint questionnaire. The secondary outcome measures were changes in performance on short-term memory and executive functions, which were assessed using standardized cognitive tests. In addition, voxel-based morphometry was performed to examine the effects of TF on changes in gray matter volume. The individuals in the TF group showed greater improvements in the total scores on the subjective memory complaint questionnaire compared with those in the placebo group. There were also significantly greater improvements in short-term memory and executive functions in the TF group relative to the placebo group. Exploratory analysis demonstrated that there were significant group-by-visit interactions on the left precuneus, right supramarginal gyrus, right middle frontal gyrus, and right postcentral gyrus at corrected P < .05. Overall frequency of adverse events did not differ among high-dose TF (40.4%), low-dose TF (35.1%), and placebo groups (41.4%). The current findings suggest that TF could be safely administered to relieve subjective memory complaints and enhance cognition in individuals with SCI.Keywords
This publication has 30 references indexed in Scilit:
- Long-Term Regeneration and Functional Recovery of a 15 mm Critical Nerve Gap Bridged byTremella fuciformisPolysaccharide-Immobilized Polylactide ConduitsEvidence-Based Complementary and Alternative Medicine, 2013
- Neurologic effects of exogenous saccharides: A review of controlled human, animal, andin vitrostudiesNutritional Neuroscience, 2012
- Optimization of extraction of Tremella fuciformis polysaccharides and its antioxidant and antitumour activities in vitroCarbohydrate Polymers, 2010
- Development of the Subjective Memory Complaints QuestionnaireDementia and Geriatric Cognitive Disorders, 2009
- Association between dietary saccharide intake and self-reported memory performance in middle-aged adultsBritish Journal of Nutrition, 2008
- Memory impairment, executive dysfunction, and intellectual decline in preclinical Alzheimer's diseaseJournal of the International Neuropsychological Society, 2008
- Ginkgo for elderly people with dementia and age-associated memory impairment: a randomized clinical trialJournal of Clinical Epidemiology, 2003
- Nutrition and Cognitive FunctionNutrition in Clinical Care, 2001
- Prevalence and Covariates of Subjective Forgetfulness in a Normal Population in the NetherlandsThe International Journal of Aging and Human Development, 1997
- The UKU side effect rating scale: A new comprehensive rating scale for psychotropic drugs and a cross‐sectional study of side effects in neuroleptic‐treated patientsActa Psychiatrica Scandinavica, 1987